Get more information on PDR's monthly Drug Updates, including the latest in FDA news and drug labeling updates.

• May 2023: Closing Treatment Gaps for Candidemia and Invasive Candidiasis
• April 2023: Alternative CGRP Option for Migraineurs
• March 2023: Increased Precision in Ovarian Cancer Therapy
• February 2023: Combating Recurrent CDI with First-in-Class Live Biotherapeutic
• January 2023: Taking a Step Closer to Ending Type 1 Diabetes
• December 2022: Neoteric Therapy for Hemophilia B
• November 2022: Improving Treatment Outcomes in Hepatorenal Syndrome
• October 2022: Help and Hope for Patients with Metastatic Breast Cancer
• September 2022: Rapid-Acting Drug Newly Approved for MDD
• August 2022: Updated Guidelines for Gastroparesis
• July 2022: Innovation in Plaque Psoriasis
• June 2022: First-in-class Type 2 Diabetes Medicine with Potential as Weight Loss Drug
• May 2022: Unprecedented Results in Treating Melanoma with Combination Immunotherapy
• April 2022: Tackling Rare Form of Chronic Daytime Sleepiness
• March 2022: Cytopenic Myelofibrosis Gets New Treatment Option
• February 2022: Reducing Limitations in Asthma Management
• January 2022: Broadened Access and First Injectable PrEP
• December 2021: Applying Real-World Evidence and Drug Targeting to Increase Transplantation Successes
• November 2021: Prescribing Options for Alcohol Use Disorder
• October 2021: Novel Treatments for a Common Neurodevelopmental Disorder
• September 2021: Taking Aim at Toxic Plaques in Alzheimer's Disease
• August 2021: Fighting Colorectal Cancer Through Screening and Targeted Therapies
• July 2021: Reducing the Risk of Recurrent Pericarditis
• June 2021: Debut of New Long-Acting HIV Medicine
• May 2021: Intriguing Therapies to Improve Life for Those with Rheumatic Disease
• April 2021: Defeating Vaccine-Preventable Disease: A Focus on Meningococcal Meningitis
• March 2021: Expanded Access to Potentially Life-Saving Glucagon
• February 2021: Profound Advancement in Early-Stage Lung Cancer Therapy
• January 2021: Targeted Therapy for Rare Genetic Disorders of Obesity
• December 2020: Exploring the Newest Treatment for Group of Rare Blood Disorders
• November 2020: Protecting Against and Treating Rare and Deadly Ebola
• October 2020: Insight into Guideline on Recurrent Uncomplicated Urinary Tract Infections in Women
• September 2020: Determining Effective Regimens for HIV
• August 2020: Battling Migraine with Innovative Approaches and Emergent Therapies
• July 2020: Growing the Armamentarium to Fight Infections from MDR Gram-Negative Organisms
• June 2020: Unique Complexities and Medication Needs of Patients with Cystic Fibrosis
• May 2020: New 2020 ACP Guideline Release on Treatment of Adult Men with Age-Related Low Testosterone
• April 2020: Understanding Peanut Allergy and Exploring New Approaches to Therapy
• March 2020: Risk Factors and Treatments for Postpartum Depression
• February 2020: Focused Update for Atrial Fibrillation Guideline
• January 2020: Blood Cholesterol Management Guidelines from the AHA/ACC
• December 2019: New Immunotherapy and Targeted Therapy Drugs for Resectable Melanoma
• November 2019: Highlights From IDWeek 2019
• October 2019: Advances in HIV Treatment and Prevention: New Data From the 2019 International AIDS Society Conference on HIV Science
• September 2019: New Advances in Initial Treatment of Chronic Lymphocytic Leukemia
• August 2019: Opioid Prescribers Can Now Find Tools and Resources to Support Their Practice
• July 2019: Expanding the Treatment Landscape of Rheumatoid Arthritis: Highlights from the 2019 European Congress of Rheumatology
• June 2019: Highlights From the 2019 International Liver Congress
• May 2019: New Approval in Advanced Renal Cell Carcinoma (RCC): Pembrolizumab Plus Axitinib
• April 2019: Closing in on HIV: Findings From the 2019 Conference on Retroviruses and Opportunistic Infections
• March 2019: Evidence of Cardioprotection With Type 2 Diabetes Drugs
• February 2019: Nonalcoholic Fatty Liver Disease: A Silent Killer
• January 2019: Opioids and HCV Continue to Provide a Double Hit to Young Adults in the United States
• December 2018: Viral Hepatitis and NASH Dominate 2018 Liver Meeting
• November 2018: Decreasing Gout Attacks by Targeting Interleukin-1β
• October 2018: Fidaxomicin for Treatment of Clostridium difficile Infection
• September 2018: Arrival of the First Digital Medicine System
• August 2018: Recommendations for Use of Herpes Zoster Vaccines
• July 2018: New in Class: ROCK Inhibitors
• June 2018: Stopping the Spread of Disease: Promising Treatments for Skin Cancer
• May 2018: Critical Changes to Hypertension Guidelines
• April 2018: Safety Labeling Changes for Pediatric Opioid Cough and Cold Preparations
• March 2018: Progression Toward a New Male Contraceptive
• February 2018: Updated COPD Guidelines
• January 2018: CAR T-Cell Therapy: An Innovative Approach to Cancer Treatment
• December 2017: Looking Back at the First Retinoid Rx-to-OTC Switch
• November 2017: Navigating the Naming System for Biologics and Biosimilars
• October 2017: Immunization Practices for Influenza and Other Viruses: Updated ACIP Recommendations for Adults
• September 2017: Increased Antibiotic Resistance in Children
• August 2017: Critical Perspectives on Prescribing Alprazolam
• July 2017: Prescribing Opioids: Guidelines for Safer Use
• June 2017: IMPORTANT UPDATE: PDR is now an all-digital publication
• May 2017: Spinal Muscular Atrophy and the Approval of Spinraza
• April 2017: Multiple Sclerosis and Emergent Treatments
• March 2017: Important Facts about Tdap and Pregnancy
• February 2017: 9-Valent HPV Vaccine: Why Are Prescribers Using More of It?
• January 2017: The Gap in Our Attention to the Gaps in Care
• December 2016: Considering the Power of the Patient Portal
• November 2016: Vital Research on Investigational Vaccines for Zika Virus Continues
• October 2016: Biosimilars—What Are the Latest Approvals and Trends?
• September 2016: Advances in Rheumatology: Strides Made in Treating Rheumatoid Arthritis and Gout
• August 2016: Redefining a Patient-Centric Approach
• July 2016: Emerging Drug Therapies for Managing Symptoms of Parkinson's Disease
• June 2016: New Melanoma Therapies
• May 2016: Metabolic Syndrome: When to Add Pharmacological Treatment
• April 2016: New Treatments and Emerging Devices for Obesity
• March 2016: Today's Cancer Vaccines
• February 2016: Checkpoint Inhibitors and Colorectal Cancer Treatment
• January 2016: Mobile Devices and Today's Healthcare Provider
• December 2015: Selecting Acne Treatments for Pediatric Patients
• November 2015: Suggesting Combined Hormonal Contraceptives
• October 2015: PDR Can Help to Promote Adherence
• September 2015: Tips to Treat Patients with Chronic Migraine
• August 2015: All New Mobile Upgrade for Physicians' Desk Reference
• July 2015: New Treatment Options for Psoriasis: Biologic Agents
• June 2015: Pharmacogenomics: Exciting Potential Benefits
• May 2015: New Oral Anticoagulants: Monitoring and Counseling Patients
• April 2015: HPV-Associated Cancer: Reducing Risks Through Prophylactic Vaccination
• March 2015: Increasing Trends in the Use of Cholesterol-Lowering Medications
• February 2015: Women and Heart Disease: Staggering Numbers
• January 2015: Vital Details to Consider While Prescribing Antidepressants
• December 2014: Updates on Preexposure Prophylaxis (PrEP) for HIV Infection
• November 2014: Targeted Therapies for Lung Cancer
• October 2014: Electronic Nicotine Delivery Systems: Under Scrutiny
• September 2014: New Product to Reverse Overdose Combats Fatal Consequences of Opioid Abuse
• August 2014: ADA Provides New HbA1c Target for Type 1 Diabetes
• July 2014: Exciting Advances in Arthritis Treatments Transform Therapeutic Goals
• June 2014: 3 Newly Approved, Child-Friendly Drugs to Aid Allergic Rhinitis Sufferers
• May 2014: Cutting Drug Costs and Improving Adherence with Pharmacy Discount Cards
• April 2014: New Orphan Drugs Bolster Advancement in Cystic Fibrosis and Other Rare Disease Therapies
• March 2014: New Drug and Treatment Therapy Can Control Complications of Chronic Kidney Disease
• February 2014: New Breakthrough Drugs Aim to Eradicate Hepatitis C Virus
• January 2014: New Diagnostic Urgency and New Pharmacotherapy for Thyroid Cancer
• December 2013: Stress and Hypertension – Lifestyle Management and Pharmacological Therapies
• November 2013: More New Diabetes Drugs; More Diabetes to Treat
• October 2013: Medication Adherence and Health Literacy: Reinforcing Effective Healthcare Communication and Practices
• September 2013: Obesity Overtaking Smoking in Cardiac Risks for the Young
• August 2013: Staying Aware of Vaccination Revisions
• July 2013: New Options for Avoiding/Treating Skin Cancer
• June 2013: Understanding and Treating Asthma and Allergies
• May 2013: The New Facts on Emergency Contraceptive Drugs
• April 2013: Treating Irritable Bowel Syndrome, A Problematic Disorder Affecting Millions
• March 2013: Improving Colorectal Cancer Survival Rates Is Critical: New approaches continue to emerge that help increase survival
• February 2013: EHR Meaningful Use Stage 2: Prepare Now